ECM
LMNL

Estabrook Capital Management’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Estabrook Capital Management’s Portfolio LMNL Stock Details LMNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-500
Closed -$3.14K – 382
2023
Q2 		$3.14K Hold
500
– – ﹤0.01% 343
2023
Q1 		$1.9K Hold
500
– – ﹤0.01% 371
2022
Q4 		$1.63K Hold
500
– – ﹤0.01% 386
2022
Q3 		$2.1K Hold
500
– – ﹤0.01% 378
2022
Q2 		$2.56K Hold
500
– – ﹤0.01% 386
2022
Q1 		$4.95K Hold
500
– – ﹤0.01% 357
2021
Q4 		$5.45K Buy
+500
New +$7.49K ﹤0.01% 367

Estabrook Capital Management's LMNL Position: Q3 2023 in Review

Estabrook Capital Management sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q3 2023, closing a stake of 500 shares — an estimated $3.14K sold.

Estabrook Capital Management first reported a position in LMNL in Q4 2021 and held it in 7 quarters. The position peaked at $5.45K in Q4 2021. 1 fund tracked by Wall St. Rank holds LMNL as of Q3 2023.

  • Estabrook Capital Management reported no remaining Liminal BioSciences Inc. Common Shares position as of Q3 2023 after selling out during the quarter.
  • Estabrook Capital Management sold 500 Liminal BioSciences Inc. Common Shares shares in Q3 2023, an estimated $3.14K.
  • Estabrook Capital Management first reported a position in Liminal BioSciences Inc. Common Shares in Q4 2021 and held it in 7 quarters.
  • Estabrook Capital Management's Liminal BioSciences Inc. Common Shares position peaked at $5.45K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q3 2023.

Based on Estabrook Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.